Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma

- Kritikos, Vicky, Harvey, Erin S., Thomas, Dennis, Gibson, Peter G., Australian Mepolizumab Registry Investigators,, Stevens, Sean, Katelaris, Constance H., Langton, David, Rimmer, Janet, Farah, Claude S., Gillman, Andrew, Hew, Mark, Radhakrishna, Naghmeh

Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry

- Thomas, Dennis, Harvey, Erin S., Bardin, Philip, Peters, Matthew, Reynolds, Paul N., Langton, David, Baraket, Melissa, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping, Farah, Claude S., McDonald, Vanessa M., Wark, Peter A. B., Gibson, Peter G., Katsoulotos, GP, Lee, J, Radhakrishna, N, Reddel, HK, Rimmer, J, Sivakumaran, P, Wark, PAB, Gibson, PG, Stevens, Sean, Upham, John W., Katelaris, Constance H., Kritikos, Vicky, Gillman, Andrew, Harrington, John, Hew, Mark

Mepolizumab effectiveness and identification of super-responders in severe asthma

- Harvey, Erin S., Langton, David, Katelaris, Constance, Stevens, Sean, Farah, Claude S., Gillman, Andrew, Harrington, John, Hew, Mark, Kritikos, Vicky, Radhakrishna, Naghmeh, Bardin, Philip, Peters, Matthew, Reynolds, Paul N., Upham, John W., Baraket, Melissa, Bowler, Simon, Bowden, Jeffrey, Chien, Jimmy, Chung, Li Ping, Grainge, Christopher, Jenkins, Christine, McDonald, Vanessa M., Wark, Peter A. B., Gibson, Peter G.